Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer

BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors prevent cell growth and have shown benefit in the treatment of metastatic colorectal cancer, whether used as single agents or in combination with chemotherapy. Clear benefit has been shown in trials of EGFR monoclonal antibodies (EGFR MA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Chan, David Lok Hang, Segelov, Eva, Wong, Rachel SH, Smith, Annabel, Herbertson, Rebecca A, Li, Bob T., Tebbutt, Niall, Price, Timothy, Pavlakis, Nick
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2017
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6481896/
https://ncbi.nlm.nih.gov/pubmed/28654140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007047.pub2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados